scholarly article | Q13442814 |
P819 | ADS bibcode | 2011PLoSO...619847N |
P356 | DOI | 10.1371/JOURNAL.PONE.0019847 |
P932 | PMC publication ID | 3100309 |
P698 | PubMed publication ID | 21625437 |
P5875 | ResearchGate publication ID | 51177511 |
P50 | author | David Gozal | Q56704818 |
P2093 | author name string | Yang Wang | |
Deepti Nair | |||
Ehab A Dayyat | |||
Shelley X Zhang | |||
P2860 | cites work | Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease | Q24308107 |
The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology | Q27860991 | ||
Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production | Q28114945 | ||
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes | Q28241500 | ||
Cytochrome b-558 alpha-subunit cloning and expression in rat aortic smooth muscle cells | Q28290518 | ||
The p47phox mouse knock-out model of chronic granulomatous disease | Q28504676 | ||
Impaired spatial working memory and altered choline acetyltransferase (CHAT) immunoreactivity and nicotinic receptor binding in rats exposed to intermittent hypoxia during sleep | Q28579395 | ||
T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation | Q28595069 | ||
Developments of a water-maze procedure for studying spatial learning in the rat | Q29617561 | ||
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat | Q29619517 | ||
Molecular mechanism underlying activation of superoxide-producing NADPH oxidases: roles for their regulatory proteins. | Q30160420 | ||
Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. | Q30336517 | ||
Behavioral and anatomical correlates of chronic episodic hypoxia during sleep in the rat. | Q33181809 | ||
Analysing hippocampal function in transgenic mice: an ethological perspective | Q33544982 | ||
Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation | Q33595388 | ||
The behavioral morbidity of obstructive sleep apnea | Q33687446 | ||
Role of Rac1 GTPase in NADPH oxidase activation and cognitive impairment following cerebral ischemia in the rat | Q33689411 | ||
NOX activity is increased in mild cognitive impairment | Q33830110 | ||
Chronic granulomatous disease. Report on a national registry of 368 patients | Q33904952 | ||
The neutrophil NADPH oxidase | Q34497891 | ||
Intermittent hypoxia is associated with oxidative stress and spatial learning deficits in the rat. | Q34531783 | ||
Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits | Q34546476 | ||
The plasma redox state and ageing | Q34662296 | ||
Glucose and NADPH oxidase drive neuronal superoxide formation in stroke. | Q35006967 | ||
Obstructive sleep apnoea and depression--diagnostic and treatment implications | Q35649912 | ||
Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases | Q35829421 | ||
The effect of chronic or intermittent hypoxia on cognition in childhood: a review of the evidence | Q35877022 | ||
C-reactive protein, obstructive sleep apnea, and cognitive dysfunction in school-aged children | Q36013631 | ||
Synaptic localization of a functional NADPH oxidase in the mouse hippocampus | Q36051340 | ||
Possible involvement of singlet oxygen species as multiple oxidants in p450 catalytic reactions | Q36071941 | ||
Manganese superoxide dismutase protects mouse cortical neurons from chronic intermittent hypoxia-mediated oxidative damage | Q36178648 | ||
Oxidative and antioxidative potential of brain microglial cells. | Q36237582 | ||
Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia | Q36380297 | ||
Effects of CPAP treatment on psychological status in patients with severe obstructive sleep apnoea. | Q51113513 | ||
The relation between fear induced by novel stimulation and exploratory behavior. | Q51364102 | ||
Antidepressant-like effect of lamotrigine in the mouse forced swimming test: Evidence for the involvement of the noradrenergic system | Q63243829 | ||
Novel approaches for cloning human genes: the chronic granulomatous disease (CGD) | Q68840202 | ||
Obstructive sleep apnea and depression | Q73068407 | ||
Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes | Q73221688 | ||
NADPH oxidase contributes directly to oxidative stress and apoptosis in nerve growth factor-deprived sympathetic neurons | Q73338159 | ||
Peroxynitrite diminishes myogenic tone in cerebral arteries: role of nitrotyrosine and F-actin | Q79240361 | ||
Cardiac swinging calcified amorphous tumors in end-stage renal failure patients | Q85246736 | ||
NADPH oxidase is required for NMDA receptor-dependent activation of ERK in hippocampal area CA1. | Q36529780 | ||
Intermittent hypoxia has organ-specific effects on oxidative stress | Q36956636 | ||
NMDA receptor activation increases free radical production through nitric oxide and NOX2. | Q37160515 | ||
NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea | Q37282593 | ||
Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion | Q37322537 | ||
The multiple challenges of obstructive sleep apnea in children: morbidity and treatment | Q37324155 | ||
NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation | Q37353163 | ||
Peroxisomes and reactive oxygen species, a lasting challenge | Q37395387 | ||
NOX enzymes in the central nervous system: from signaling to disease | Q37421768 | ||
NADPH oxidase signaling and cardiac myocyte function. | Q37449222 | ||
Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase | Q37456875 | ||
Green tea catechin polyphenols attenuate behavioral and oxidative responses to intermittent hypoxia | Q38448137 | ||
Stress-induced activation of Nox contributes to cell survival signalling via production of hydrogen peroxide | Q39864384 | ||
Impaired spatial learning and hyperactivity in developing rats exposed to intermittent hypoxia | Q40637968 | ||
Expression and modulation of an NADPH oxidase in mammalian astrocytes. | Q42484955 | ||
Physical activity attenuates intermittent hypoxia-induced spatial learning deficits and oxidative stress | Q42734293 | ||
Nox4-dependent H2O2 production contributes to chronic glutamate toxicity in primary cortical neurons. | Q43110515 | ||
Apocynin attenuate spatial learning deficits and oxidative responses to intermittent hypoxia | Q43190731 | ||
Functional evaluation of nonphagocytic NAD(P)H oxidases | Q44037745 | ||
Brain morphology associated with obstructive sleep apnea | Q44159112 | ||
Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients | Q44178014 | ||
Cyclooxygenase 2 and intermittent hypoxia-induced spatial deficits in the rat. | Q44457712 | ||
Increased susceptibility to intermittent hypoxia in aging rats: changes in proteasomal activity, neuronal apoptosis and spatial function | Q44570078 | ||
NADPH oxidase immunoreactivity in the mouse brain | Q44602831 | ||
Platelet-activating factor receptor-deficient mice are protected from experimental sleep apnea-induced learning deficits | Q44804975 | ||
Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions | Q44881796 | ||
Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test. | Q45063835 | ||
Antioxidant responses to chronic hypoxia in the rat cerebellum and pons. | Q45950247 | ||
Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia | Q46414453 | ||
Taxol induces oxidative neuronal cell death by enhancing the activity of NADPH oxidase in mouse cortical cultures | Q46451301 | ||
Types of coping strategies are associated with increased depressive symptoms in patients with obstructive sleep apnea | Q46812151 | ||
Apolipoprotein E-deficient mice exhibit increased vulnerability to intermittent hypoxia-induced spatial learning deficits | Q46840840 | ||
Children's sleep and adjustment over time: the role of socioeconomic context | Q46896567 | ||
Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea | Q47319965 | ||
The effects of breathing-related sleep disorders on mood disturbances in the general population | Q47338460 | ||
Intermittent hypoxic exposure during light phase induces changes in cAMP response element binding protein activity in the rat CA1 hippocampal region: water maze performance correlates | Q48143111 | ||
Reactive oxygen species plasmatic levels in ischemic stroke | Q48223426 | ||
Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. | Q48486252 | ||
High fat/refined carbohydrate diet enhances the susceptibility to spatial learning deficits in rats exposed to intermittent hypoxia. | Q48502263 | ||
Nitric oxide synthase and intermittent hypoxia-induced spatial learning deficits in the rat. | Q48581819 | ||
The influence of open arm ledges and maze experience in the elevated plus-maze. | Q48635740 | ||
Relationship between quality of life and mood or depression in patients with severe obstructive sleep apnea syndrome. | Q48651059 | ||
The effects of continuous positive air pressure treatment on anxiety and depression levels in apnea patients. | Q48677336 | ||
Developmental differences in cortical and hippocampal vulnerability to intermittent hypoxia in the rat. | Q48691300 | ||
Neurobehavioral manifestations in obstructive sleep apnea syndrome before and after treatment with continuous positive airway pressure | Q48881392 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hypoxia | Q105688 |
murine model | Q122890741 | ||
P304 | page(s) | e19847 | |
P577 | publication date | 2011-05-23 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Intermittent hypoxia-induced cognitive deficits are mediated by NADPH oxidase activity in a murine model of sleep apnea | |
P478 | volume | 6 |
Q46256199 | A Mini-Review of the NADPH oxidases in Vascular Dementia: Correlation with NOXs and Risk Factors for VaD. |
Q47639493 | Activating adenosine A1 receptor accelerates PC12 cell injury via ADORA1/PKC/KATP pathway after intermittent hypoxia exposure |
Q36525556 | Adverse cognitive effects of high-fat diet in a murine model of sleep apnea are mediated by NADPH oxidase activity |
Q49524953 | Alzheimer's Disease Mutant Mice Exhibit Reduced Brain Tissue Stiffness Compared to Wild-type Mice in both Normoxia and following Intermittent Hypoxia Mimicking Sleep Apnea. |
Q64859151 | Androgens modulate chronic intermittent hypoxia effects on brain and behavior |
Q36831267 | Association of sleep disordered breathing and cognitive deficit in APOE ε4 carriers |
Q38759460 | Biological plausibility linking sleep apnoea and metabolic dysfunction |
Q40703345 | Bone mineral density and changes in bone metabolism in patients with obstructive sleep apnea syndrome. |
Q45891807 | Bone mineral density in patients with obstructive sleep apnea syndrome |
Q88481493 | Brain-derived erythropoietin protects from intermittent hypoxia-induced cardiorespiratory dysfunction and oxidative stress in mice |
Q39440737 | C/EBP homologous binding protein (CHOP) underlies neural injury in sleep apnea model |
Q36366284 | Cerebrovascular consequences of obstructive sleep apnea |
Q38106888 | Chronic intermittent hypoxia and hypertension: a review of systemic inflammation and Chinese medicine. |
Q35063989 | Chronic intermittent hypoxia exerts CNS region-specific effects on rat microglial inflammatory and TLR4 gene expression. |
Q47664264 | Chronic intermittent hypoxia exposure induces kidney injury in growing rats |
Q35030798 | Chronic intermittent hypoxia increases rat sternohyoid muscle NADPH oxidase expression with attendant modest oxidative stress. |
Q33566982 | Chronic intermittent hypoxia-induced deficits in synaptic plasticity and neurocognitive functions: a role for brain-derived neurotrophic factor. |
Q39413926 | Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity |
Q36791654 | Cognition and biomarkers of oxidative stress in obstructive sleep apnea |
Q48106142 | Cognition and nocturnal disturbance in OSA: the importance of accounting for age and premorbid intelligence |
Q55255406 | Cognitive Deficits Are Attenuated in Neuroglobin Overexpressing Mice Exposed to a Model of Obstructive Sleep Apnea. |
Q35650259 | Cognitive function in prepubertal children with obstructive sleep apnea: a modifying role for NADPH oxidase p22 subunit gene polymorphisms? |
Q38251100 | Connections between sleep and cognition in older adults |
Q45189885 | CrossTalk proposal: the intermittent hypoxia attending severe obstructive sleep apnoea does lead to alterations in brain structure and function |
Q38080761 | Death by a thousand cuts in Alzheimer's disease: hypoxia--the prodrome |
Q28387166 | Disrupted sleep without sleep curtailment induces sleepiness and cognitive dysfunction via the tumor necrosis factor-α pathway |
Q58787803 | Dysfunction of Nrf2-ARE Signaling Pathway: Potential Pathogenesis in the Development of Neurocognitive Impairment in Patients with Moderate to Severe Obstructive Sleep Apnea-Hypopnea Syndrome |
Q37973295 | Dysfunctional nucleus tractus solitarius: its crucial role in promoting neuropathogenetic cascade of Alzheimer's dementia--a novel hypothesis |
Q28079155 | Emerging co-morbidities of obstructive sleep apnea: cognition, kidney disease, and cancer |
Q40177344 | Environmental Enrichment Prevent the Juvenile Hypoxia-Induced Developmental Loss of Parvalbumin-Immunoreactive Cells in the Prefrontal Cortex and Neurobehavioral Alterations Through Inhibition of NADPH Oxidase-2-Derived Oxidative Stress |
Q34325029 | Exogenous erythropoietin administration attenuates intermittent hypoxia-induced cognitive deficits in a murine model of sleep apnea |
Q37346715 | GRK5 deficiency leads to susceptibility to intermittent hypoxia-induced cognitive impairment. |
Q35875682 | Glucoregulatory consequences and cardiorespiratory parameters in rats exposed to chronic-intermittent hypoxia: effects of the duration of exposure and losartan |
Q47777325 | Gray Matter Hypertrophy and Thickening with Obstructive Sleep Apnea in Middle-aged and Older Adults |
Q37364745 | Growth hormone releasing hormone (GHRH) signaling modulates intermittent hypoxia-induced oxidative stress and cognitive deficits in mouse |
Q36115297 | Human apolipoprotein E4 targeted replacement in mice reveals increased susceptibility to sleep disruption and intermittent hypoxia |
Q33759821 | Inflammatory markers and obstructive sleep apnea in obese children: the NANOS study |
Q35178707 | Influence of gonadal hormones on the behavioral effects of intermittent hypoxia in mice |
Q47111060 | Inhibition of microRNA-218 reduces HIF-1α by targeting on Robo1 in mice aortic endothelial cells under intermittent hypoxia |
Q41015700 | Intermittent Hypoxia-Induced Parvalbumin-Immunoreactive Interneurons Loss and Neurobehavioral Impairment is Mediated by NADPH-Oxidase-2. |
Q36260699 | Intermittent hypoxia causes NOX2-dependent remodeling of atrial connexins |
Q47774432 | Late gestational intermittent hypoxia induces metabolic and epigenetic changes in male adult offspring mice |
Q35003150 | Long-term intermittent hypoxia elevates cobalt levels in the brain and injures white matter in adult mice. |
Q36490066 | Making sense of oxidative stress in obstructive sleep apnea: mediator or distracter? |
Q38739054 | Mechanisms of microglial activation in models of inflammation and hypoxia: Implications for chronic intermittent hypoxia |
Q90370879 | Multiple chronic conditions: Implications for cognition - Findings from the Wisconsin Registry for Alzheimer's Prevention (WRAP) |
Q84781338 | NADPH oxidase-dependent oxidative stress and mitochondrial damage in hippocampus of D-galactose-induced aging rats |
Q33632673 | New insights on NOX enzymes in the central nervous system |
Q38098921 | Obstructive sleep apnea and delirium: exploring possible mechanisms |
Q89216818 | Obstructive sleep apnoea syndrome |
Q37661360 | Oxidative stress and psychological disorders |
Q36477283 | P2X7 Receptor Antagonism Attenuates the Intermittent Hypoxia-induced Spatial Deficits in a Murine Model of Sleep Apnea Via Inhibiting Neuroinflammation and Oxidative Stress |
Q36635045 | Pathogenesis of cognitive dysfunction in patients with obstructive sleep apnea: a hypothesis with emphasis on the nucleus tractus solitarius |
Q37015491 | Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndrome |
Q50437287 | Prenatal high sucrose intake affected learning and memory of aged rat offspring with abnormal oxidative stress and NMDARs/Wnt signaling in the hippocampus. |
Q46617003 | Prolonged Exposures to Intermittent Hypoxia Promote Visceral White Adipose Tissue Inflammation in a Murine Model of Severe Sleep Apnea: Effect of Normoxic Recovery |
Q37694131 | Protective effect of 3-(naphthalen-2-yl(propoxy)methyl)azetidine hydrochloride on hypoxia-induced toxicity by suppressing microglial activation in BV-2 cells |
Q33569634 | Resveratrol attenuates intermittent hypoxia-induced macrophage migration to visceral white adipose tissue and insulin resistance in male mice |
Q28066757 | Role of Oxidative Stress in the Neurocognitive Dysfunction of Obstructive Sleep Apnea Syndrome |
Q47652448 | Sex differences in sleep apnea and comorbid neurodegenerative diseases. |
Q92772563 | Sleep and circadian rhythm disruption and stress intersect in Alzheimer's disease |
Q33903186 | Sleep apnea: a redox edge with aging? |
Q37700389 | Sleep fragmentation in mice induces nicotinamide adenine dinucleotide phosphate oxidase 2-dependent mobilization, proliferation, and differentiation of adipocyte progenitors in visceral white adipose tissue |
Q35683048 | Sleep fragmentation induces cognitive deficits via nicotinamide adenine dinucleotide phosphate oxidase-dependent pathways in mouse |
Q34285497 | Targeting NOX enzymes in the central nervous system: therapeutic opportunities. |
Q38263008 | Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium |
Q54314640 | The Relationship between Obstructive Sleep Apnea and Alzheimer's Disease. |
Q57157334 | The association of sleep-disordered breathing and white matter hyperintensities in heart failure patients |
Q35853134 | The link between angiotensin II-mediated anxiety and mood disorders with NADPH oxidase-induced oxidative stress |
Q33913792 | The polymorphic and contradictory aspects of intermittent hypoxia |
Q99551730 | The role of reactive oxygen species in cognitive impairment associated with sleep apnea |
Q36905339 | Urinary neurotransmitters are selectively altered in children with obstructive sleep apnea and predict cognitive morbidity |
Q47772610 | Visceral White Adipose Tissue after Chronic Intermittent and Sustained Hypoxia in Mice. |
Q36702523 | Which NADPH oxidase isoform is relevant for ischemic stroke? The case for nox 2. |
Search more.